August Editorial: impact factors
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach
Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis
Potent cardioprotection from ischemia–reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor
proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke
Genome-wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: Genetics In Familial Thrombosis study
Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation
Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels
An adaptive-design dose-ranging study of PD 0348292, an oral factor Xa inhibitor, for thromboprophylaxis after total knee replacement surgery
An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura
Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool
The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate
Micro-Ribonucleic Acid 494 regulation of protein S expression
Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells
Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in vitro and in vivo study
Phosphorylation of CalDAG-GEFI by protein kinase A prevents Rap1b activation
Activated platelets correlate with mobilization of naïve CD34+ cells and generation of CD34+/KDR+ cells in the circulation. A meta-regression analysis
Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH
The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH
A guide to GRADE guidelines for the readers of JTH
Impact of polymorphisms affecting the ACP1 gene on levels of antibodies against platelet factor 4–heparin complexes
Lipid rafts contribute to agonist-induced serine/threonine phosphatase activation and platelet aggregation
Uncertainty of International Sensitivity Index and International Normalized Ratio
Lack of strong effect modification by NFE2L2 / CYP3A5 / ABO of the risk of venous thrombosis associated with oral hormone therapy
Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast-enhanced computed tomography imaging in cancer patients
Obituary of Patrick Gaffney
Join ISTH